Evidence map›Paper›PMID 35022341›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer.

Yuta Kawaguchi, Sayaka Kuba, Michi Morita, Xiangyue Meng, Hiroko Hayashi, Kazuma Kobayashi, Tomohiko Adachi, Masaaki Hidaka, Shinichiro Itoh, Kengo Kanetaka and 1 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yuta KawaguchiDepartment of Surgery, Yamaguchi Prefectural Grand Medical Center, Japan.
Sayaka KubaDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Michi MoritaDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Xiangyue MengDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Hiroko HayashiDepartment of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Kazuma KobayashiDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Tomohiko AdachiDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Masaaki HidakaDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Shinichiro ItohDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Kengo KanetakaDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Susumu EguchiDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Nagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 66-year-old woman underwent partial mastectomy and a sentinel lymph node biopsy for left breast cancer; the pathological diagnosis was invasive ductal carcinoma (pT1aN0, pStage I, triple-negative subtype). Postoperative radiotherapy was performed. Two years later, she developed redness and induration at both breasts. The diagnosis was bilateral inflammatory breast cancer. After four cycles of dose-dense epirubicin and cyclophosphamide followed by 12 weekly paclitaxel cycles, bilateral total mastectomy and axillary lymph node dissection were performed. At the one-year follow-up after undergoing operation and radiotherapy, she remained alive without recurrence. Dose-dense treatment regimens may help patients achieve complete resection without short-term recurrence.

Indexed as

Breast NeoplasmsInflammatory Breast NeoplasmsTriple Negative Breast NeoplasmsAgedAntineoplastic Combined Chemotherapy ProtocolsEpirubicinFemaleHumansLymph Node ExcisionMastectomySentinel Lymph Node BiopsyEpirubicinbilateral inflammatory breast cancerdose-dense chemotherapytriple-negative breast cancer

Identifiers

PMID35022341
PMCPMC9424078
OpenAlexW4206221265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.